title: [The efficacy of recombinant alfa-2 interferon in viral hepatitis B].
authors.forename: A F
authors.initials: AF
authors.lastname: Frolov
authors.forename: A D
authors.initials: AD
authors.lastname: Vovk
authors.forename: S T
authors.initials: ST
authors.lastname: Diadiun
authors.forename: S V
authors.initials: SV
authors.lastname: Antonenko
authors.forename: I A
authors.initials: IA
authors.lastname: Petrovskaia
authors.forename: S V
authors.initials: SV
authors.lastname: Fedorchenko
authors.forename: L Ia
authors.initials: LIa
authors.lastname: Kushko
authors.forename: S N
authors.initials: SN
authors.lastname: Antoniak
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D006509:Hepatitis B / Q000097:blood / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D007372:Interferons / Q000097:blood; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology; D008875:Middle Aged; D011994:Recombinant Proteins; D013997:Time Factors
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins; D007372:Interferons
vernacular_title: Effektivnost' rekombinantnogo al'fa 2-interferona pri virusnom gepatite B.